Therefore, we hypothesize that the relatively subtle degree of thrombocytopenia detected in our Lman1-null mice would likely be missed among the diverse population of human patients with F5F8D, particularly given that a 20%–30% reduction in platelet count is still well within the normal range. This evidence concerns the gene LMAN1 and Thrombocytopenia.